Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check5 days agoChange DetectedUpdated the study page to revision v3.3.3 with a reorganized Locations section listing new site locations (Arkansas, California, North Carolina, Pennsylvania, Utah). The HHS Vulnerability Disclosure link was removed.SummaryDifference0.6%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPublications section updated to indicate that publications are automatically filled from PubMed and may not be about the study, and to reflect revision v3.3.2; the previous wording described PubMed-origin publications and referenced revision v3.2.0.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved a general government funding/operating status notice from the page. The study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.4%

- Check55 days agoChange DetectedThe new screenshot preserves the same study details and sections as the previous version; there are no core content additions or deletions detected, and any differences are limited to layout or styling.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference5%

- Check90 days agoChange DetectedUpdated page to v3.1.0 with removal of drug-safety/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and addition of the version tag.SummaryDifference0.6%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.